[1]
Radwan, B. and Boşgelmez, İ.İ. 2019. The Safety of Chelators for Iron Overload in Sickle Cell Disease: A Brief Systematic Review. Acta Medica. 50, 3 (Sep. 2019), 50–60. DOI:https://doi.org/10.32552/2019.ActaMedica.368.